Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy.

Oncology (Williston Park, N.Y.) - 1 Dec 2015

Finnigan John P, Rubinsteyn Alex, Hammerbacher Jeffrey, Bhardwaj Nina

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Cancer Vaccines
Share to Immunotherapy
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms

Share to Precision Medicine

Source

Identifiers

PMID: 26676902

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy.PMID 26676902Read ↗

Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancerSemantic proximity Read ↗

Harnessing Tumor Mutations for Truly Individualized Cancer VaccinesSemantic proximity Read ↗

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinicSemantic proximity Read ↗

Cancer immunotherapy: broadening the scope of targetable tumours.Semantic proximity Read ↗

Mutational and Antigenic Landscape in Tumor Progression and Cancer ImmunotherapySemantic proximity Read ↗

Co-mutations in tumor immune microenvironment and immunotherapy.Semantic proximity Read ↗

Persistent mutations render cancer cells susceptible to immunotherapy.Semantic proximity Read ↗

Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies.Semantic proximity Read ↗

Tumor antigens.Semantic proximity Read ↗

Targeting cancer-specific mutations by T cell receptor gene therapy.Semantic proximity Read ↗

Mutation-Derived Neoantigens for Cancer ImmunotherapySemantic proximity Read ↗

Tumor neoantigens: building a framework for personalized cancer immunotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.